Health
Molecular imaging can predict response to novel metastatic breast cancer treatment – News-Medical.Net
Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal…
Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy. According to research published in the February issue of the Journal of Nuclear Medicine, positron emission tomography (PET) imaging using an imaging agent called 18F-fluoroestradiol can help to determine which patients could benefit from treatments that could spare them from unnecessary chemotherapy.
Nearly two-thirds of…
-
General20 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News16 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General9 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News9 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership